chr2-127574029-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_001393586.1(MYO7B):āc.702A>Gā(p.Gln234=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,613,950 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.0060 ( 9 hom., cov: 33)
Exomes š: 0.00060 ( 9 hom. )
Consequence
MYO7B
NM_001393586.1 synonymous
NM_001393586.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.720
Genes affected
MYO7B (HGNC:7607): (myosin VIIB) The protein encoded by this gene is found in brush border microvilli of epithelial cells in the intestines and kidneys. The encoded protein is involved in linking protocadherins to the actin cytoskeleton and is essential for proper microvilli function. This protein aids in the accumulation of intermicrovillar adhesion components such as harmonin and ANKS4B, and this accumulation is necessary for normal brush border action. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 2-127574029-A-G is Benign according to our data. Variant chr2-127574029-A-G is described in ClinVar as [Benign]. Clinvar id is 3038652.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.72 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.006 (913/152258) while in subpopulation AFR AF= 0.0209 (868/41562). AF 95% confidence interval is 0.0197. There are 9 homozygotes in gnomad4. There are 419 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYO7B | NM_001393586.1 | c.702A>G | p.Gln234= | synonymous_variant | 7/48 | ENST00000409816.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYO7B | ENST00000409816.8 | c.702A>G | p.Gln234= | synonymous_variant | 7/48 | 1 | NM_001393586.1 | ||
MYO7B | ENST00000428314.5 | c.702A>G | p.Gln234= | synonymous_variant | 7/47 | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00600 AC: 913AN: 152140Hom.: 9 Cov.: 33
GnomAD3 genomes
AF:
AC:
913
AN:
152140
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00160 AC: 399AN: 249142Hom.: 4 AF XY: 0.00133 AC XY: 180AN XY: 135178
GnomAD3 exomes
AF:
AC:
399
AN:
249142
Hom.:
AF XY:
AC XY:
180
AN XY:
135178
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000602 AC: 880AN: 1461692Hom.: 9 Cov.: 31 AF XY: 0.000535 AC XY: 389AN XY: 727126
GnomAD4 exome
AF:
AC:
880
AN:
1461692
Hom.:
Cov.:
31
AF XY:
AC XY:
389
AN XY:
727126
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00600 AC: 913AN: 152258Hom.: 9 Cov.: 33 AF XY: 0.00563 AC XY: 419AN XY: 74458
GnomAD4 genome
AF:
AC:
913
AN:
152258
Hom.:
Cov.:
33
AF XY:
AC XY:
419
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
MYO7B-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 04, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at